v3.25.4
Schedule of Restricted Share Units (Details) - $ / shares
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]    
Number of shares, Unvested, beginning balance 400,757 201,273
Weighted average grant date fair value per share, Unvested, beginning balance $ 5.22 $ 8.33
Number of shares, Granted 140,762 [1] 277,726 [2],[3]
Weighted average grant date fair value per share, Granted $ 7.53 [1] $ 3.83 [2],[3]
Number of shares, Vested (159,169) (76,213)
Weighted average grant date fair value per share, Vested $ 5.18 $ 8.00
Number of shares, Forfeited (50,141) (2,029)
Weighted average grant date fair value per share, Forfeited $ 4.98 $ 17.50
Number of shares, Unvested, ending balance 332,209 400,757
Weighted average grant date fair value per share, Unvested, ending balance $ 6.26 $ 5.22
[1] On October 14, 2025, the Company granted 140,762 RSUs to executives and employees of the Company, which vest in one-third increments on October 14, 2026, June 30 of 2027 and 2028. The vesting of these RSUs resulted in stock-based compensation of $108,970 for the year ended December 31, 2025, which is included in operation and administration expenses on the consolidated statements of loss and comprehensive loss.
[2] On January 29, 2024, the Company granted 19,216 RSUs to executives and employees of the Company, which vest on January 29, 2025. The vesting of these RSUs resulted in stock-based compensation of $50,000 for the year ended December 31, 2024, which is included in operation and administration expenses on the consolidated statements of loss and comprehensive loss.
[3] On March 13, 2024, the Company granted 258,513 RSUs to executives and employees of the Company, which vest in one-third increments on March 31 of 2025, 2026 and 2027. The vesting of these RSUs resulted in stock-based compensation of $361,690 for the year ended December 31, 2024, which is included in operation and administration expenses on the consolidated statements of loss and comprehensive loss.